Status:
AVAILABLE
Expanded Access to Elezanumab
Lead Sponsor:
AbbVie
Conditions:
Acute Spinal Cord Injury (SCI)
Eligibility:
All Genders
18+ years
Brief Summary
This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to Elezanumab prior to approval by the local regulatory agency. Availability will depend ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- \- The participant must not be eligible for an elezanumab clinical trial.
Exclusion
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04278235
Last Update
July 10 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.